“MET-Mediated Drug Resistance in Colorectal Cancer: In Silico Analysis of the Potential of Epicatechin-3-Gallate and Epigallocatechin-3-Gallate As Therapeutic Adjuvants”. Integrated Health Research Journal 3, no. (1-Supp) (June 1, 2026): 05–16. Accessed August 19, 2026. https://journal.ucc.edu.gh/index.php/ihrj/article/view/2075.